Literature DB >> 23574968

Prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Constantinos O'Mahony1, Perry M Elliott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23574968     DOI: 10.1136/heartjnl-2012-301996

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  7 in total

Review 1.  Inherited cardiomyopathies.

Authors:  Jeffrey A Towbin
Journal:  Circ J       Date:  2014-09-02       Impact factor: 2.993

Review 2.  Risk Stratification in Hypertrophic Cardiomyopathy.

Authors:  Alexandros Klavdios Steriotis; Sanjay Sharma
Journal:  Eur Cardiol       Date:  2015-07

3.  Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Authors:  K Weber; N Rostert; S Bauersachs; G Wess
Journal:  Mol Cell Biochem       Date:  2015-01-09       Impact factor: 3.396

4.  Amino Acid Changes at Arginine 204 of Troponin I Result in Increased Calcium Sensitivity of Force Development.

Authors:  Susan Nguyen; Rylie Siu; Shannamar Dewey; Ziyou Cui; Aldrin V Gomes
Journal:  Front Physiol       Date:  2016-11-15       Impact factor: 4.566

Review 5.  Diagnostic and prognostic roles of echocardiography and cardiac magnetic resonance.

Authors:  Victoria Delgado; Chiara Bucciarelli-Ducci; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2016-07-29       Impact factor: 5.952

6.  Risk Stratification for Primary Prevention of Sudden Cardiac Death in Hypertrophic Cardiomyopathy.

Authors:  Styliani Vakrou; Charalampos Vlachopoulos; Konstantinos A Gatzoulis
Journal:  Arq Bras Cardiol       Date:  2021-07       Impact factor: 2.000

7.  Sudden Cardiac Death Risk over Time in HCM Patients with Implantable Cardioverter-Defibrillator.

Authors:  Mariusz Klopotowski; Krzysztof Kukula; Jacek Jamiolkowski; Artur Oreziak; Maciej Dabrowski; Zbigniew Chmielak; Adam Witkowski
Journal:  J Clin Med       Date:  2022-03-16       Impact factor: 4.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.